A somatic mutation in the coding sequence of the AKT1 gene previously identified in breast, ovarian and colon cancers could not be identified in a panel of 109 GBM samples and 9 high-grade astrocytoma cell lines [25], indicating that AKT activation in GBMs was not mediated by this activating mutation. This evidence concerns the gene AKT1 and glioblastoma.